Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1972 1
1975 1
1977 1
1982 1
1983 2
1984 2
1985 2
1986 3
1987 6
1988 7
1989 2
1991 6
1992 1
1993 12
1994 8
1995 1
1996 2
1997 4
1998 8
1999 3
2000 4
2001 5
2002 8
2003 3
2004 2
2005 2
2006 5
2007 9
2008 6
2009 9
2010 8
2011 9
2012 5
2013 6
2014 7
2015 6
2016 8
2017 5
2018 3
2019 9
2020 6
2021 10
2022 7
2023 3
2024 5
2025 4
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

214 results

Results by year

Filters applied: . Clear all
Page 1
Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia.
Miyagawa N, Goto H, Ogawa A, Kikuta A, Kosaka Y, Sekimizu M, Tomizawa D, Toyoda H, Hiramatsu H, Hara J, Mochizuki S, Nakayama H, Yoshimura K, Iijima-Yamashita Y, Sanada M, Ogawa C. Miyagawa N, et al. Among authors: kikuta a. Int J Hematol. 2023 Aug;118(2):267-276. doi: 10.1007/s12185-023-03609-8. Epub 2023 May 1. Int J Hematol. 2023. PMID: 37127801 Clinical Trial.
Defective Epstein-Barr virus in chronic active infection and haematological malignancy.
Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, Inoue M, Kawa K, Seto M, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Narita Y, Yoshida M, Goshima F, Kawada JI, Nishida T, Kiyoi H, Kato S, Nakamura S, Morishima S, Yoshikawa T, Fujiwara S, Shimizu N, Isobe Y, Noguchi M, Kikuta A, Iwatsuki K, Takahashi Y, Kojima S, Ogawa S, Kimura H. Okuno Y, et al. Among authors: kikuta a. Nat Microbiol. 2019 Mar;4(3):404-413. doi: 10.1038/s41564-018-0334-0. Epub 2019 Jan 21. Nat Microbiol. 2019. PMID: 30664667
[Drug-induced purpura].
Kikuta A, Suzuki H. Kikuta A, et al. Ryoikibetsu Shokogun Shirizu. 1998;(21 Pt 2):412-5. Ryoikibetsu Shokogun Shirizu. 1998. PMID: 9833529 Review. Japanese. No abstract available.
[Henoch-Schönlein purpura].
Kikuta A, Suzuki H. Kikuta A, et al. Ryoikibetsu Shokogun Shirizu. 1998;(21 Pt 2):408-11. Ryoikibetsu Shokogun Shirizu. 1998. PMID: 9833528 Review. Japanese. No abstract available.
Results of a Phase II Trial for Intermediate-Risk Rhabdomyosarcoma Treatment Protocol JRS-I: A Report From the Japan Rhabdomyosarcoma Study Group.
Kikuta A, Masaki H, Hojo H, Hata JI, Ohkita H, Hosoi H, Nakazawa A, Hinotsu S, Ikeda H, Kishimoto S, Kaneko M, Kawai A, Hara J, Takimoto T, Kato M, Kaneko T, Kosaka Y, Morikawa Y; Japan Rhabdomyosarcoma Study Group (JRSG). Kikuta A, et al. Pediatr Blood Cancer. 2025 Oct;72(10):e31894. doi: 10.1002/pbc.31894. Epub 2025 Jul 3. Pediatr Blood Cancer. 2025. PMID: 40611548 Clinical Trial.
Phase 1/2 study of a WT1 peptide-dosing emulsion in pediatric patients with recurrent/refractory diffuse intrinsic pontine glioma, glioblastoma, or anaplastic astrocytoma.
Hashii Y, Fujisaki H, Terashima K, Goto H, Horibe K, Sugiyama K, Takahara-Matsubara M, Goto M, Yanagisawa T, Kikuta A, Kawamoto H, Hashimoto N, Oka Y, Sugiyama H, Hara J. Hashii Y, et al. Among authors: kikuta a. Eur J Cancer. 2026 Jun 25;242:116808. doi: 10.1016/j.ejca.2026.116808. Epub 2026 May 19. Eur J Cancer. 2026. PMID: 42176363 Clinical Trial.
214 results